Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Team Grant: GACD Lung Diseases

McMaster University

$307,011.00

Examining the impact of tobacco pricing and packaging strategies on tobacco use and equity in middle-income countries

FY 2015-16

Summary
Tobacco use causes more than 6 million deaths per year worldwide, a number that is expected to rise to more than 8 million by 2030, and most of which will be occurring in low- and middle-income countries. Smoking is the leading cause of lung disease: smoking causes chronic obstructive pulmonary disease (COPD) (including emphysema and chronic bronchitis) and most cases of lung cancer; smokers are about 12 times more likely to die from COPD than nonsmokers and 25 times more likely to develop lung cancer. We will study the impact of tobacco prices on smoking onset, smoking cessation, and tobacco consumption in Chile, Colombia, Ecuador, South Africa, and Vietnam. The effects of both tax and retail price will be further analyzed according to their effect by socioeconomic status, sex, and age with simulations to determine the ultimate impacts on tax revenue, tobacco use, and health outcomes. Additionally, the impact of cigarette packaging, including plain packaging, and major recent country-specific policy changes will be analyzed. There is overwhelming evidence that higher cigarette prices reduce tobacco use with greater reductions among young people and those from more socioeconomically disadvantaged groups. The tobacco industry, however, asserts that tobacco taxes harm vulnerable populations and lead to increased consumption of illicit cigarettes and that packaging policies are ineffective. Evidence generated by this research will be used to address these claims with the aim of influencing tax policy and tobacco product labeling practices in low- and middle-income countries with the goal of ultimately preventing ill health and deaths caused by tobacco consumption.
Program
Team Grant: GACD Lung Diseases
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
349003
Name
Guindon Godefroy E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
International Development Research Centre (Ottawa); South African Medical Research Council
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Team Grant: GACD Lung Diseases
Projecttitle
Examining the impact of tobacco pricing and packaging strategies on tobacco use and equity in middle-income countries
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$307,011
Cihrequipment2
$0
Programname2
Team Grant: GACD Lung Diseases
Keyworddelim
Econometrics; Economics; Equity; Experimental Economic; Packaging Policies; Pricing Policies; Smoking; Taxation Policies; Tobacco
Abstract
Tobacco use causes more than 6 million deaths per year worldwide, a number that is expected to rise to more than 8 million by 2030, and most of which will be occurring in low- and middle-income countries. Smoking is the leading cause of lung disease: smoking causes chronic obstructive pulmonary disease (COPD) (including emphysema and chronic bronchitis) and most cases of lung cancer; smokers are about 12 times more likely to die from COPD than nonsmokers and 25 times more likely to develop lung cancer. We will study the impact of tobacco prices on smoking onset, smoking cessation, and tobacco consumption in Chile, Colombia, Ecuador, South Africa, and Vietnam. The effects of both tax and retail price will be further analyzed according to their effect by socioeconomic status, sex, and age with simulations to determine the ultimate impacts on tax revenue, tobacco use, and health outcomes. Additionally, the impact of cigarette packaging, including plain packaging, and major recent country-specific policy changes will be analyzed. There is overwhelming evidence that higher cigarette prices reduce tobacco use with greater reductions among young people and those from more socioeconomically disadvantaged groups. The tobacco industry, however, asserts that tobacco taxes harm vulnerable populations and lead to increased consumption of illicit cigarettes and that packaging policies are ineffective. Evidence generated by this research will be used to address these claims with the aim of influencing tax policy and tobacco product labeling practices in low- and middle-income countries with the goal of ultimately preventing ill health and deaths caused by tobacco consumption.
Competitiondate
201603
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Guindon, Godefroy E; Blecher, Evan; Marquez, Patricio; Gallego, Juan M; Hoang Anh, Pham Thi; Paraje, Guillermo; Ross, Hana; Van Walbeek, Corne; Villacres, Tatiana
Approvedterm
5 ans 0 mois
Cihrcontribution2
Inst of Cancer Research~ $102,337~ $0~Inst of Circ &Respiratory Hlth~ $102,337~ $0~Inst of Population &Publ Hlth~ $102,337~ $0~
McMaster University - $307,011 Grant (2015-16) | Canada Spends